1. Home
  2. VYNE vs MI Comparison

VYNE vs MI Comparison

Compare VYNE & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • MI
  • Stock Information
  • Founded
  • VYNE 2003
  • MI 2009
  • Country
  • VYNE United States
  • MI Hong Kong
  • Employees
  • VYNE N/A
  • MI N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • MI Catalog/Specialty Distribution
  • Sector
  • VYNE Health Care
  • MI Consumer Discretionary
  • Exchange
  • VYNE Nasdaq
  • MI Nasdaq
  • Market Cap
  • VYNE 41.9M
  • MI 38.8M
  • IPO Year
  • VYNE 2018
  • MI N/A
  • Fundamental
  • Price
  • VYNE $2.98
  • MI $3.27
  • Analyst Decision
  • VYNE Strong Buy
  • MI
  • Analyst Count
  • VYNE 2
  • MI 0
  • Target Price
  • VYNE $6.88
  • MI N/A
  • AVG Volume (30 Days)
  • VYNE 122.3K
  • MI 87.8K
  • Earning Date
  • VYNE 11-07-2024
  • MI 01-01-0001
  • Dividend Yield
  • VYNE N/A
  • MI N/A
  • EPS Growth
  • VYNE N/A
  • MI N/A
  • EPS
  • VYNE N/A
  • MI 1.16
  • Revenue
  • VYNE $493,000.00
  • MI $1,273,946.00
  • Revenue This Year
  • VYNE $32.31
  • MI N/A
  • Revenue Next Year
  • VYNE N/A
  • MI N/A
  • P/E Ratio
  • VYNE N/A
  • MI $2.57
  • Revenue Growth
  • VYNE 39.27
  • MI N/A
  • 52 Week Low
  • VYNE $1.57
  • MI $2.05
  • 52 Week High
  • VYNE $4.09
  • MI $16.70
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 59.02
  • MI 30.75
  • Support Level
  • VYNE $2.65
  • MI $2.05
  • Resistance Level
  • VYNE $3.05
  • MI $10.29
  • Average True Range (ATR)
  • VYNE 0.23
  • MI 1.34
  • MACD
  • VYNE -0.05
  • MI -0.64
  • Stochastic Oscillator
  • VYNE 34.57
  • MI 13.71

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About MI NFT Limited

NFT Ltd Formerly Takung Art Co Ltd operates an online electronic platform for offering and trading artwork. Through its platform, the company allows artists/art dealers/owners to access a much bigger art trading market where artists can engage with a wide range of investors. Its platform also invests in high-end artwork accessible to ordinary people without financial resources. The company's trading platforms comprise the sale of calligraphies and paintings, jewelry, and precious stones. It generates revenue in the form of services in connection with the offering and trading of artwork on its system, consisting of listing fees, trading commissions, and management fees.

Share on Social Networks: